Immeasurable time bias exaggerates drug benefits in pharmacoepidemiologic studies due to exposure misclassification that occurs due to the lack of inpatient drug data in many healthcare databases. Click to show full abstract
Immeasurable time bias exaggerates drug benefits in pharmacoepidemiologic studies due to exposure misclassification that occurs due to the lack of inpatient drug data in many healthcare databases.
               
Click one of the above tabs to view related content.